Insulin Aspart Injection and Ranibizumab Intraocular
Determining the interaction of Insulin Aspart Injection and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart Injection-Ranibizumab ophthalmic
- Insulin Aspart Injection-Ranitidine
- Insulin Aspart Injection-Ranitidine Capsule
- Insulin Aspart Injection-Ranitidine Hydrochloride
- Insulin Aspart Injection-Ranitidine Injection
- Insulin Aspart Injection-Ranitidine Suspension
- Ranibizumab Intraocular-Insulin Aspart Protamine and Insulin Aspart
- Ranibizumab Intraocular-Insulin aspart protamine and insulin aspart Subcutaneous
- Ranibizumab Intraocular-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Ranibizumab Intraocular-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Ranibizumab Intraocular-Insulin Aspart Protamine Injection
- Ranibizumab Intraocular-Insulin aspart, recombinant Subcutaneous